SECTION I · THE BRIEF
Brief #01233Updated 28 AUG 2026WATERTOWN, MAGreenhouseMEDICAL ORGANIZATIONS
Employbl Company Profile

Associate Director or Director, Clinical Scientist

Kymera Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the…

Location
Watertown, MA
Company size
253–253
Posted
Today
Via
Greenhouse
Section II · Full ProfileFree with an account
  • 01Comp band & equity packageLocked
  • 02Seniority & experience requirementsLocked
  • 03Interview process & rubricLocked
  • 04Hiring manager & team contextLocked
  • 05Growth trajectory in this roleLocked
  • 06Offer & decision timelineLocked

Free account · no card · 2 minutes

Kymera Therapeutics logo

Associate Director or Director, Clinical Scientist · Kymera Therapeutics

View company profile
Job title
Associate Director or Director, Clinical Scientist
Job location
Watertown, MA
Job description

Who we are:

Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn

 

How we work:

  • PIONEER: We are courageous, resilient and rigorous in our mission to improve patients’ lives through our revolutionary degrader medicines.
  • COLLABORATE: We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine.
  • BELONG: We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard.

 

How you’ll make an impact:

  • Serve as the study level Clinical Scientist in immunology, with a focus on dermatologic indications, actively participating in study team meetings, vendor meetings, and data/safety monitoring committees.
  • Support the design of clinical trial protocols and amendments, ensuring scientific integrity and alignment with regulatory standards. Collaborate with Translational Medicine to integrate biomarker testing and with Clinical Pharmacology to integrate pharmacokinetic sampling into trial protocols.
  • Prepare and review essential documents such as medical monitoring plans, statistical analysis plans, informed consent forms, case report forms and clinical study reports.
  • Support study execution as scientific subject matter expert.
  • Conduct clinical data reviews, including safety monitoring activities, to ensure patient safety and data accuracy and integrity.
  • Data review, cleaning, and monitoring utilizing data visualization tools, and protocol deviations review to analyze trends, identify risks and implement mitigation strategies.
  • Support IRB and regulatory submissions and query responses.
  • Present data and information to external investigators and internal stakeholders, contributing to meetings with governance bodies and regulatory authorities.
  • Work within a matrix environment, collaborating with medical directors, regulatory affairs, translational medicine, clinical operations, data management, biostatistics, and other departments to drive clinical development programs forward. 

 

Skills and experience you’ll bring:

  • Bachelor’s or advanced degree (MSc, PharmD, PhD) in Life Sciences or related field and 8+ years in pharmaceutical clinical drug development, with experience in global clinical trials and program execution.
  • Experience in immunological diseases with an understanding of disease biology and treatment landscapes; Experience with clinical trials for dermatologic indications and endpoints is a plus.
  • In-depth understanding of clinical development processes, regulatory requirements, and guidelines (FDA, EMEA, ICH, GCP).
  • Strong critical-thinking, problem-solving abilities and excellent medical writing skills.
  • Maintain a patient-centric mentality throughout the drug development process. 

                                                                                                                                                                                

Equal Employment Opportunity

Kymera Therapeutics is proud to be an equal opportunity employer, seeking to create a welcoming and diverse environment.  All applicants will receive consideration for employment without regard to race, color, religion, creed, gender, national origin, age, disability, veteran status, pregnancy, sex, marital status, gender expression or identity, genetic information, sexual orientation, citizenship, or any other legally protected class.

 

Compensation

  • Kymera offers a competitive compensation package that recognizes both results and capabilities through market-based, performance-driven pay.
  • The anticipated base salary range for this role is $160,000 – $275,000, with eligibility for annual bonus, equity participation, and comprehensive benefits.
  • Actual salary is based on a holistic evaluation of the specific role/level as well as each candidate’s depth of experience and the capabilities they bring to the position.

 

 

View job listing ↗
The Saturday Briefing

Get the Saturday tech briefing

New company profiles, funding moves, and who’s hiring across the market — every Saturday morning.

Kymera Therapeutics headquarters

Watertown, MA

Company size

253253 employees

Founded

2017

Total raised

$1,956,800,000

View company profile ↗

Funding rounds

  • Post Ipo Equity$602M
  • Post Ipo Equity$250.8M
  • Post Ipo Equity$225M
  • Post Ipo Equity$275M
  • Post Ipo Equity$150M
  • Post Ipo Equity$257M
  • Series C$102M
  • IPOUndisclosed
  • Series B$65M
  • Series A$30M